<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="reply"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Indian J Ophthalmol</journal-id><journal-id journal-id-type="publisher-id">Indian Journal of Ophthalmology</journal-id><journal-title-group><journal-title>Indian Journal of Ophthalmology</journal-title></journal-title-group><issn pub-type="ppub">0301-4738</issn><issn pub-type="epub">1998-3689</issn><publisher><publisher-name>Medknow Publications</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">2636068</article-id><article-id pub-id-type="publisher-id">IndianJOphthalmol_2008_56_1_85_37588</article-id><article-categories><subj-group subj-group-type="heading"><subject>Letter To Editor</subject></subj-group></article-categories><title-group><article-title>Authors&#x02032; reply</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Shukla</surname><given-names>Dhananjay</given-names></name><degrees>MS</degrees></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Ramasamy</given-names></name><degrees>DNB</degrees></contrib><aff>Retina-Vitreous Service, Aravind Eye Hospital and Postgraduate Institute of Ophthalmology, Madurai, Tamil Nadu, India. E-mail: <email>daksh@aravind.org / daksh66@gmail.com</email></aff></contrib-group><pub-date pub-type="ppub"><season>Jan-Feb</season><year>2008</year></pub-date><volume>56</volume><issue>1</issue><fpage seq="a">85</fpage><lpage>85</lpage><permissions><copyright-statement>Copyright: &#x000a9; Indian Journal of Ophthalmology</copyright-statement><copyright-year>2008</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><related-article related-article-type="letter" vol="26" page="84" ext-link-type="pmc" id="RA1"><article-title>Trans-pupillary thermotherapy for circumscribed choroidal hemangioma</article-title></related-article></article-meta></front><body><p>Dear Editor,</p><p>We thank Rishi <italic>et al</italic>.<xref ref-type="bibr" rid="ref1">1</xref> for creating the opportunity to extendthe discussion on the management options for circumscribedchoroidal hemangioma (CCH). The question raised is  &#x02033;Whywas transpupillary thermotherapy (TTT) not attempted againafter the initial failure, as successfully done by them<xref ref-type="bibr" rid="ref1">1</xref> as wellas by Garcia-Arumi <italic>et al</italic>.?<xref ref-type="bibr" rid="ref2">2</xref>&#x02033;</p><p>To respond to the query: we neither practice nor are awareof any report (including Garcia-Arumi&#x02032;s) that recommendsre-treatment in CCH or for that matter, any pathology, witha treatment modality that causes significant and persistentworsening of both functional and anatomical status after thefirst attempt. The increased retinal detachment (RD) with 2-line drop in vision was managed conservatively for a monthwithout success, after which we offered photodynamic therapy,a safer and more effective alternative, as one of the options;withholding the offending initial treatment.<xref ref-type="bibr" rid="ref3">3</xref> The tumor in ourpatient was 3.2-mm thick, with a base diameter of 6.0 mm.</p><p>Garcia-Arumi <italic>et al</italic>.<xref ref-type="bibr" rid="ref2">2</xref> did report a modest post-TTT increasein RD in three cases. However, they also mentioned that itsubsided spontaneously in each case within two to three weeks.Their indication for re-treatment was incomplete re-absorptionof fluid; not a worsening of preexisting RD, as happened in ourcase. Therefore, we can&#x02032;t derive treatment guidelines from theirexperience. In fact, the status of our patient&#x02032;s eye one monthafter TTT (total RD) fitted into Garcia-Arumi&#x02032;s exclusion criteriafor TTT.<xref ref-type="bibr" rid="ref2">2</xref></p><p>The case described by Rishi <italic>et al</italic>.<xref ref-type="bibr" rid="ref1">1</xref> fits into Garcia-Arumi&#x02032;sexclusion criteria for TTT: total bullous RD, with tumor height&#x0003e;3.5 mm.<xref ref-type="bibr" rid="ref2">2</xref> They must be congratulated for their successfuloutcome, which extends the scope of TTT. However, neitherof these two reports constitutes a standard-of-care treatmentrecommendation for CCH, for which, treatment must beindividualized as per the situation at hand, as we mentionedin the first line under discussion.<xref ref-type="bibr" rid="ref3">3</xref> Additionally, we note withsurprise that this letter reports a dramatically improved visualoutcome of 20/40 at three-year follow-up in contrast to thepoor visual recovery (10/200) stable for 10 months after TTTin the published report, which explained the poor outcome bysubfoveal tumor location.<xref ref-type="bibr" rid="ref1">1</xref></p><p>We reported a new modality for successful treatment of CCHrefractory to TTT, which adds to the armamentarium of existingtreatment options. We reiterate that we do not recommendre-treatment of CCH with TTT when it results in significantaggravation of the pre-treatment status.</p></body><back><ref-list><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rishi</surname><given-names>P</given-names></name><name><surname>Sharma</surname><given-names>T</given-names></name></person-group><article-title>Transpupillary thermotherapy for large-sized subfoveal circumscribed choroidal haemangioma</article-title><source>Retina</source><year>2006</year><volume>26</volume><fpage>974</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">17031306</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Arumi</surname><given-names>J</given-names></name><name><surname>Ramsay</surname><given-names>LS</given-names></name><name><surname>Guraya</surname><given-names>BC</given-names></name></person-group><article-title>Therapeutic options for capillary papillary hemangiomas</article-title><source>Ophthalmology</source><year>2000</year><volume>107</volume><fpage>48</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">10647718</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shukla</surname><given-names>D</given-names></name><name><surname>Ramasamy</surname><given-names>K</given-names></name></person-group><article-title>Vitrectomy for circumscribed choroidal hemangioma with exudative retinal detachment refractory to transpupillary thermotherapy</article-title><source>Indian J Ophthalmol</source><year>2007</year><volume>55</volume><fpage>298</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">17595480</pub-id></element-citation></ref></ref-list></back></article>